Evaluation of Selenium Concentrations in Patients with Crohn’s Disease and Ulcerative Colitis

Autor: Michał Chalcarz, Beniamin Oskar Grabarek, Tomasz Sirek, Agata Sirek, Piotr Ossowski, Mateusz Wilk, Katarzyna Król-Jatręga, Konrad Dziobek, Julia Gajdeczka, Jarosław Madowicz, Damian Strojny, Kacper Boroń, Jakub Żurawski

Publikováno v: Biomedicines, Vol 12, Iss 10, p 2167 (2024)

Background/Objectives: In this study, serum selenium levels in patients with Crohn’s disease (CD) and ulcerative colitis (UC) were evaluated to identify potential predictive markers of disease activity. Conducted in 100 inflammatory bowel disease (

Externí odkaz: https://doaj.org/article/0e8ff282a7784b18bb99fc0cbdd98970

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cigarette smoking adversely affects disease activity and disease-specific quality of life in patients with Crohn’s disease at a tertiary referral center

Autor: Quezada SM, Langenberg P, Cross RK

Publikováno v: Clinical and Experimental Gastroenterology, Vol Volume 9, Pp 307-310 (2016)

Sandra M Quezada,1 Patricia Langenberg,2 Raymond K Cross1 1Division of Gastroenterology and Hepatology, 2Division of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA Purpose: Smoking has a negative impact

Externí odkaz: https://doaj.org/article/475fcebbb1ba4d6787f45ca335e66d9a

Predictors of health-related quality of life in patients with Crohn’s disease receiving biological therapy

Autor: Peter Haastrup, Jens Kjeldsen, Bjørn Rasmussen, Lasse R Lundquist, Frans Boch Waldorff, Sonja Wehberg

Publikováno v: Lundquist, L, Kenneth Rasmussen, B, Waldorff, F B, Wehberg, S, Kjeldsen, J & Haastrup, P 2021, ' Predictors of health-related quality of life in patients with Crohn’s disease receiving biological therapy ', Scandinavian Journal of Gastroenterology, vol. 56, no. 12, pp. 1434-1441 . https://doi.org/10.1080/00365521.2021.1974086

Background and Aim: Health-related quality of life (HRQoL) is impaired in patients with Crohn’s disease (CD). This study aimed to identify the impact of clinical disease activity on HRQoL in CD patients treated with biological agents. Methods: Pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccefc93b35215905b2ed5bd80d932899
https://portal.findresearcher.sdu.dk/da/publications/e682fcf7-b7e0-446a-a88a-ff509d5c156b

Relación de los parámetros farmacocinéticos de exposición a Infliximab con la remisión clínica y biológica en pacientes con enfermedad inflamatoria intestinal

Autor: Lobato Martínez, María

Hypotheses and objectives: Pharmacotherapeutic monitoring in patients with Inflammatory bowel disease (IBD) treated with anti-TNF may be of clinical benefit. The purpose is to determine the correlation between the pharmacokinetics of IFX with clinica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4721::8ff787ec988256da4d801e5b7c6c38ff
https://hdl.handle.net/20.500.12466/2825